These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 19130464

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Non-surgical tissue biopsy among patients with advanced pancreatic cancer: effect on survival.
    Hernandez LV, Bhutani MS, Eisner M, Guda NM, Lu N, Geenen JE, Catalano MF.
    Pancreas; 2009 Apr; 38(3):289-92. PubMed ID: 19136909
    [Abstract] [Full Text] [Related]

  • 26. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM, Meyer JE, Sherr DL.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1128-33. PubMed ID: 18538501
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.
    Gaur P, Leary C, Yao JC.
    Ann Surg; 2010 Jun 15; 251(6):1117-21. PubMed ID: 20485130
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.
    Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW.
    Br J Surg; 2008 May 15; 95(5):627-35. PubMed ID: 18306152
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N, Vigano' L, Razzore P, Langella S, Motta M, Bertuzzo F, Papotti M, Ferrero A.
    Eur J Surg Oncol; 2015 Jun 15; 41(6):751-7. PubMed ID: 25887286
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
    Pomianowska E, Gladhaug IP, Grzyb K, Røsok BI, Edwin B, Bergestuen DS, Mathisen O.
    Scand J Gastroenterol; 2010 Aug 15; 45(7-8):971-9. PubMed ID: 20441530
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N, Hodson J, Marudanayagam R, Sutcliffe RP, Isaac JR, Ayuk J, Shah T, Roberts KJ.
    Hepatobiliary Pancreat Dis Int; 2018 Apr 15; 17(2):169-175. PubMed ID: 29576279
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
    Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E.
    Scand J Gastroenterol; 2014 Jun 15; 49(6):734-41. PubMed ID: 24679166
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.